Bipartisan congressional efforts have become a rarity. But during a push and pull over biomedical R&D funding, House Republicans recently strayed from the party line to try and keep the money flowing. In a fiscal 2026 spending bill released this week, GOP lawmakers held NIH funding steady at $48 billion instead of the Trump administration’s proposed 40% cuts. While the bill isn’t likely to get far in the legislative process, the move sends a signal that the House is at least willing to put politics aside to maintain federal research investments, which used to be considered a bipartisan goal.

For researchers, the financial winds are already shifting away from the U.S., and governments elsewhere are happy to reel them in. Today, we’re exploring how Europe and the U.K. have become appealing to U.S. researchers as destinations for work — and the incentives they’re providing to inspire scientists to make the leap.

Thanks for reading.